1. JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-1. Acute myeloid leukemia (AML)

   • Hitoshi Kiyoi
   • Hiroki Yamaguchi
   • Takahiro Yamauchi

   Guideline 23 March 2020 Pages: 595 - 613

   

2. Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting

   • Giovanni Caocci
   • Maria Pina Simula
   • Giorgio La Nasa

   Rapid Communication 23 March 2020 Pages: 614 - 618

   

3. Guest editorial: B1 cells: their ontogeny and malignant counterpart

   • Naoyuki Katayama

   Progress in Hematology 08 April 2020 Pages: 619 - 621

4. The ontogeny of murine B-1a cells

   • Momoko Yoshimoto

   Progress in Hematology 04 December 2019 Pages: 622 - 627

   

5. Ontogeny of human B1 cells

   • Yuki Kageyama
   • Naoyuki Katayama

   Progress in Hematology 12 November 2019 Pages: 628 - 633

   

6. Pathophysiology of chronic lymphocytic leukemia and human B1 cell development

   • Yoshikane Kikushige

   Progress in Hematology 03 December 2019 Pages: 634 - 641

   

7. Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?

   • Junji Suzumiya
   • Jun Takizawa

   Progress in Hematology 06 April 2020 Pages: 642 - 656

8. Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia

   • Akihito Kitao
   • Shinichiro Kawamoto
   • Hironobu Minami

   Original Article 30 January 2020 Pages: 657 - 666

   

9. Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series

   • Satoshi Ichikawa
   • Noriko Fukuhara
   • Hideo Harigae

   Original Article 18 January 2020 Pages: 667 - 672

   

10. Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma

    • Yasuo Mori
    • Ilseung Choi
    • Fukuoka Blood and Marrow Transplantation Group

    Original Article 24 January 2020 Pages: 673 - 680

    

11. Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma

    • Yongqiang Wei
    • Xiaolei Wei
    • Ru Feng

    Original Article 28 January 2020 Pages: 681 - 685

    

12. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy

    • Akihiko Sawaki
    • Kana Miyazaki
    • Naoyuki Katayama

    Original Article 28 January 2020 Pages: 686 - 691

13. Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study

    • Hiroyuki Takamatsu
    • Shinsuke Iida
    • Kenshi Suzuki

    Original Article 30 January 2020 Pages: 692 - 701

    

14. Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation

    • Tomonari Shigemura
    • Kazuo Sakashita
    • Yozo Nakazawa

    Original Article 18 January 2020 Pages: 702 - 710

    

15. Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

    • Yuhki Koga
    • Masahiro Sekimizu
    • Keizo Horibe

    Original Article 20 January 2020 Pages: 711 - 718

    

16. Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia

    • Masao Hagihara
    • Jian Hua
    • Tomoiku Takaku

    Case Report 01 January 2020 Pages: 719 - 723

    

17. Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

    • Naoki Tamura
    • Hirona Maeda
    • Akifumi Takaori-Kondo

    Case Report 01 January 2020 Pages: 724 - 732

    

18. Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation

    • Hiroshi Ureshino
    • Takero Shindo
    • Shinya Kimura

    Case Report 23 December 2019 Pages: 733 - 738

    

19. In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide

    • Masatoshi Sakurai
    • Hiroshi Takemoto
    • Satoshi Yamazaki

    Letter to the Editor 12 March 2020 Pages: 739 - 741

    

20. Do small increases in serum ferritin impact prognosis in lower-risk MDS patients?

    • Anacelia Gomes de Matos Mota
    • Priscila da Silva Mendonça
    • Silvia Maria Meira Magalhães

    Letter to the Editor 09 March 2020 Pages: 742 - 744

21. Correction to: Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area

    • Daisuke Nakamura
    • Makoto Yoshimitsu
    • Kenji Ishitsuka

    Correction 06 March 2020 Pages: 745 - 745